Published in Mol Cancer on September 18, 2008
SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell (2011) 3.71
Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81
Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev Res (Phila) (2012) 1.66
MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics (2012) 1.56
Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer (2010) 1.50
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer Metab (2014) 1.48
A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One (2012) 1.40
Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One (2011) 1.35
Implementing prognostic and predictive biomarkers in CRC clinical trials. Nat Rev Clin Oncol (2011) 1.31
A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics (2010) 1.30
Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS One (2010) 1.28
Identification of functional modules that correlate with phenotypic difference: the influence of network topology. Genome Biol (2010) 1.25
The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol (2011) 1.22
Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One (2012) 1.20
Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics (2011) 1.17
GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis. Nat Chem Biol (2011) 1.15
Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study. BMC Genomics (2012) 1.10
Diagnostics: The prostate-cancer metabolome. Nature (2009) 1.09
Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol (2012) 1.07
Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiol Biomarkers Prev (2013) 1.03
Postgenomics diagnostics: metabolomics approaches to human blood profiling. OMICS (2013) 1.03
Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci (2009) 1.03
Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets. OMICS (2011) 1.01
Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries. Autophagy (2013) 0.97
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. Pharmacogenomics J (2012) 0.95
Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry. J Gastroenterol (2011) 0.94
Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res (2013) 0.94
Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology (2014) 0.93
Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies. Genome Med (2012) 0.90
Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J Proteome Res (2014) 0.87
Identification of defense compounds in Barbarea vulgaris against the herbivore Phyllotreta nemorum by an ecometabolomic approach. Plant Physiol (2009) 0.86
Beneficial Regulation of Metabolic Profiles by Black Raspberries in Human Colorectal Cancer Patients. Cancer Prev Res (Phila) (2015) 0.85
Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses. PLoS One (2010) 0.84
Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis (2014) 0.84
Bioactive food components and cancer-specific metabonomic profiles. J Biomed Biotechnol (2010) 0.84
Metabolic signatures differentiate ovarian from colon cancer cell lines. J Transl Med (2015) 0.83
Direct detection of diverse metabolic changes in virally transformed and tax-expressing cells by mass spectrometry. PLoS One (2010) 0.83
Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther (2014) 0.81
Black raspberries suppress colonic adenoma development in ApcMin/+ mice: relation to metabolite profiles. Carcinogenesis (2015) 0.80
Enhanced production of 2,3-butanediol by engineered Saccharomyces cerevisiae through fine-tuning of pyruvate decarboxylase and NADH oxidase activities. Biotechnol Biofuels (2016) 0.79
Identification of cancer mechanisms through computational systems modeling. Transl Cancer Res (2014) 0.79
Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression. J Proteome Res (2015) 0.79
Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism. Oxid Med Cell Longev (2015) 0.79
A metabolic study on colon cancer using (1)h nuclear magnetic resonance spectroscopy. Biochem Res Int (2014) 0.79
From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer. Genes (Basel) (2014) 0.78
Serum metabolomics analysis for early detection of colorectal cancer. J Gastroenterol (2016) 0.78
Biomarker Discovery and Translation in Metabolomics. Curr Metabolomics (2016) 0.77
A distinct metabolic signature predicts development of fasting plasma glucose. J Clin Bioinforma (2012) 0.77
Advances in gas chromatographic methods for the identification of biomarkers in cancer. J Cancer (2012) 0.76
Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage. Anal Chem (2015) 0.76
Metabolomics of ApcMin/+ mice genetically susceptible to intestinal cancer. BMC Syst Biol (2014) 0.76
Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance. Hum Mol Genet (2017) 0.75
NMR metabolic fingerprints of murine melanocyte and melanoma cell lines: application to biomarker discovery. Sci Rep (2017) 0.75
Quantitative proteomic profiling of paired cancerous and normal colon epithelial cells isolated freshly from colorectal cancer patients. Proteomics Clin Appl (2016) 0.75
Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer. Gastroenterol Res Pract (2017) 0.75
Serum Metabolomics of Burkitt Lymphoma Mouse Models. PLoS One (2017) 0.75
Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer. PLoS One (2015) 0.75
Altered Mitochondrial Signalling and Metabolism in Cancer. Front Oncol (2017) 0.75
Glycolysis in patients with age-related macular degeneration. Open Ophthalmol J (2014) 0.75
Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia. Front Genet (2016) 0.75
Clustering Based on Periodicity in High-Throughput Time Course Data. Stat Anal Data Min (2011) 0.75
Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine. Hypoxia (Auckl) (2017) 0.75
Environmental influences in the etiology of colorectal cancer: the premise of metabolomics. Curr Pharmacol Rep (2017) 0.75
Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocr Relat Cancer (2017) 0.75
[Metabolome analysis of solid tumors]. Pathologe (2016) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet (2005) 17.75
Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol (2002) 11.36
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell (2007) 9.20
Metabolite profiling for plant functional genomics. Nat Biotechnol (2000) 8.74
Glycolysis inhibition for anticancer treatment. Oncogene (2006) 6.55
Extension of the visualization tool MapMan to allow statistical analysis of arrays, display of corresponding genes, and comparison with known responses. Plant Physiol (2005) 4.34
Potential of metabolomics as a functional genomics tool. Trends Plant Sci (2004) 4.10
Metabolic profiles of cancer cells. Nat Rev Cancer (2004) 3.21
Metabolic targeting as an anticancer strategy: dawn of a new era? Sci STKE (2007) 2.71
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res (2006) 2.68
Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res (2000) 2.47
SetupX--a public study design database for metabolomic projects. Pac Symp Biocomput (2007) 2.20
A protocol for building and evaluating predictors of disease state based on microarray data. Bioinformatics (2005) 2.08
Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem (2005) 1.96
Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc Natl Acad Sci U S A (2005) 1.75
Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci (2004) 1.73
Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. Int J Cancer (2007) 1.48
Visualizing plant metabolomic correlation networks using clique-metabolite matrices. Bioinformatics (2001) 1.44
GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J Physiol Pharmacol (1998) 0.98
Functional genomics: lessons from yeast. Philos Trans R Soc Lond B Biol Sci (2002) 0.94
Increased aspartate and glutamate levels in both gastric and colon cancer tissues. Tokushima J Exp Med (1993) 0.91
Nutritional regulation of gene expression. Am J Med (1999) 0.87
Diet, folate, and colon cancer. Curr Opin Gastroenterol (2002) 0.81
Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol (2008) 12.96
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat (2009) 7.91
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol (2009) 7.21
Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics (2007) 6.93
Slug and Sox9 cooperatively determine the mammary stem cell state. Cell (2012) 4.77
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol (2012) 4.30
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol (2013) 4.11
Potential of metabolomics as a functional genomics tool. Trends Plant Sci (2004) 4.10
FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem (2009) 3.71
Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics (2007) 3.70
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2014) 3.40
A proposed framework for the description of plant metabolomics experiments and their results. Nat Biotechnol (2004) 3.32
A comprehensive urinary metabolomic approach for identifying kidney cancerr. Anal Biochem (2007) 3.14
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol (2008) 3.12
Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics (2006) 3.02
Quality control for plant metabolomics: reporting MSI-compliant studies. Plant J (2008) 2.97
Process for the integrated extraction, identification and quantification of metabolites, proteins and RNA to reveal their co-regulation in biochemical networks. Proteomics (2004) 2.81
HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch (2010) 2.72
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res (2006) 2.68
A prominent role for the CBF cold response pathway in configuring the low-temperature metabolome of Arabidopsis. Proc Natl Acad Sci U S A (2004) 2.64
Differential metabolic networks unravel the effects of silent plant phenotypes. Proc Natl Acad Sci U S A (2004) 2.63
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol (2011) 2.56
The metabolomics standards initiative. Nat Biotechnol (2007) 2.54
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell (2011) 2.47
The metabolic signature related to high plant growth rate in Arabidopsis thaliana. Proc Natl Acad Sci U S A (2007) 2.44
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur Urol (2007) 2.40
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res (2008) 2.36
Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics (2009) 2.21
SetupX--a public study design database for metabolomic projects. Pac Symp Biocomput (2007) 2.20
CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res (2003) 2.15
Subsidence of the wing titanium cage after anterior cervical interbody fusion: 2-year follow-up study. J Neurosurg Spine (2006) 2.13
Natural genetic variation of freezing tolerance in Arabidopsis. Plant Physiol (2006) 2.10
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer (2008) 2.10
Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A (2009) 2.08
Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res (2011) 2.07
An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators. J Thorac Oncol (2014) 1.97
Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. Anal Biochem (2002) 1.93
Systems rebalancing of metabolism in response to sulfur deprivation, as revealed by metabolome analysis of Arabidopsis plants. Plant Physiol (2005) 1.89
Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol (2008) 1.89
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol (2010) 1.85
The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol (2010) 1.81
Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res (2004) 1.79
LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat Methods (2013) 1.78
Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer (2006) 1.78
Advances in structure elucidation of small molecules using mass spectrometry. Bioanal Rev (2010) 1.76
Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc Natl Acad Sci U S A (2005) 1.75
Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. Cancer Res (2009) 1.75
Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol (2011) 1.75
Identification of metabolic and biomass QTL in Arabidopsis thaliana in a parallel analysis of RIL and IL populations. Plant J (2007) 1.74
How large is the metabolome? A critical analysis of data exchange practices in chemistry. PLoS One (2009) 1.73
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Res Treat (2010) 1.63
A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol (2010) 1.63
Pseudo-pseudo Meigs' syndrome. Lancet (2005) 1.63
Metabolite profiling of Chlamydomonas reinhardtii under nutrient deprivation. Plant Physiol (2005) 1.62
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS One (2012) 1.61
Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol (2006) 1.59
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res (2004) 1.58
MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics (2012) 1.56
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer (2003) 1.55
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Mod Pathol (2010) 1.55
A prognostic gene expression index in ovarian cancer - validation across different independent data sets. J Pathol (2009) 1.55
The volatile compound BinBase mass spectral database. BMC Bioinformatics (2011) 1.55
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate (2003) 1.54
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer (2006) 1.53
A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology (2009) 1.52